These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19289925)

  • 1. Adjuvant treatment with vindesine for metastatic melanoma: in response to the study of Eigentler et al. (2008).
    Retsas S; Quigley M; Pectasides D; Henry K
    Melanoma Res; 2009 Apr; 19(2):123-4. PubMed ID: 19289925
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
    Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy of malignant melanoma: is there a choice?
    Retsas S
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):187-93. PubMed ID: 11682325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents.
    Emmert S; Zutt M; Haenssle H; Neumann C; Kretschmer L
    Melanoma Res; 2003 Jun; 13(3):299-302. PubMed ID: 12777986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of melanoma.
    Wargo JA; Tanabe K
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):565-81, x. PubMed ID: 19464603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vindesine in oncology--recommendations after 10 years' experience.
    Dancey J; Steward WP
    Anticancer Drugs; 1995 Oct; 6(5):625-36. PubMed ID: 8845472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The history and future of chemotherapy for melanoma.
    Yang AS; Chapman PB
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):583-97, x. PubMed ID: 19464604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised trial of vindesine plus interferon-alpha 2b compared with interferon-alpha 2b or vindesine alone in the treatment of advanced malignant melanoma.
    Vorobiof DA; Bezwoda WR
    Eur J Cancer; 1994; 30A(6):797-800. PubMed ID: 7917540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant high-dose interferon therapy for high-risk melanoma.
    Ready N; Weinstock MA
    Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
    [No Abstract]   [Full Text] [Related]  

  • 12. Sydney Melanoma Unit patients in breach of multicentre selective lymphadenectomy trial protocol?
    Thomas JM
    ANZ J Surg; 2006 Nov; 76(11):1038-9; author reply 1039-40. PubMed ID: 17054559
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
    Glaspy J; Atkins MB; Richards JM; Agarwala SS; O'Day S; Knight RD; Jungnelius JU; Bedikian AY
    Cancer; 2009 Nov; 115(22):5228-36. PubMed ID: 19728370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute gout during treatment with paclitaxel for metastatic melanoma.
    Alexandrescu DT; Ichim TE; Kabigting F; Dasanu CA
    Rheumatology (Oxford); 2009 Jul; 48(7):862-3. PubMed ID: 19458161
    [No Abstract]   [Full Text] [Related]  

  • 15. LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).
    Agarwala SS; Keilholz U; Gilles E; Bedikian AY; Wu J; Kay R; Stein CA; Itri LM; Suciu S; Eggermont AM
    Eur J Cancer; 2009 Jul; 45(10):1807-14. PubMed ID: 19419855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized multicenter ESHO-study: Hyperthermia improves results in recurrent and metastatic malignant melanoma].
    Seegenschmiedt MH
    Strahlenther Onkol; 1996 May; 172(5):276-8. PubMed ID: 8633262
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of patients with Langerhans cell histiocytosis with vindesine.
    Hirose M; Ishimoto K; Ninomiya T; Kuroda Y
    J Pediatr Hematol Oncol; 1996 Nov; 18(4):421-2. PubMed ID: 8888759
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of metastatic melanoma.
    Cohen SM
    Mt Sinai J Med; 1992 May; 59(3):220-3. PubMed ID: 1351249
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
    Garrido-Laguna I; Ponz M; Espinós J
    J Clin Oncol; 2007 Mar; 25(9):1149; author reply 1149-51. PubMed ID: 17369585
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use?
    Joel S
    Cancer Treat Rev; 1996 Nov; 21(6):513-25. PubMed ID: 8599802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.